Search Ontology:
ChEBI

alvocidib

Term ID
CHEBI:47344
Synonyms
  • (-)-cis-5,7-dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one
  • 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-4H-chromen-4-one
  • alvocidib
  • alvocidibum
  • Flavopiridol
  • HMR 1274
  • HMR-1274
  • L 86-8275
  • L 868275
  • L-868275
  • L86-8275
Definition
A synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is substituted by a 3-hydroxy-1-methylpiperidin-4-yl group at position 8 and by a chlorine at the 2' position (the (−)-3S,4R stereoisomer). A cyclin-dependent kinase 9 (CDK9) inhibitor, it has been studied for the treatment of acute myeloid leukaemia, arthritis and atherosclerotic plaque formation.
References
  • cas:146426-40-6
  • drugbank:DB03496
  • kegg.drug:D09868
  • lincs.smallmolecule:LSM-1011
  • patent:EP241003
  • patent:US4900727
  • pdb-ccd:CPB
  • pubmed:10441105
  • pubmed:1279187
  • pubmed:18209094
  • pubmed:21541623
  • pubmed:23959599
  • pubmed:25118834
  • pubmed:25216351
  • pubmed:25351763
  • pubmed:25623777
  • pubmed:25860066
  • pubmed:25989942
  • pubmed:26022709
  • pubmed:26521988
  • pubmed:26599132
  • pubmed:8002990
  • pubmed:9269999
  • pubmed:9815683
  • wikipedia.en:Alvocidib
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alvocidib
Phenotype where environments contain alvocidib
Phenotype modified by environments containing alvocidib
Phenotype affecting alvocidib
Human Disease Model